-
公开(公告)号:US20240005767A1
公开(公告)日:2024-01-04
申请号:US18039359
申请日:2021-11-29
Applicant: Eran AHARONSON , Tal Tzvi WEINBERG , MOR RESEARCH APPLICATIONS LTD.
Inventor: Eran AHARONSON , Tal Tzvi WEINBERG , Gil ZALSMAN
CPC classification number: G08B21/0469 , A61B5/1118 , A61B5/4561
Abstract: Embodiments pertain to a non-wearable monitoring system for monitoring activity of a human in a scene including a floor. The system may comprise a plurality of remote ranging emitters which are configured to emit ranging energy towards the scene. At least one first and at least one second emitter of the plurality of emitters are arranged to cover different height sections of the scene. The plurality of remote ranging emitters is arranged to obtain, based on the emitted ranging energy, reflections. The system further comprises a plurality of sensors which are configured to receive the reflections and to convert the reflections into electronic signals to generate reflection-based data. The system is configured to determine based on the reflection-based data, a posture and/or activity of the human in the scene.
-
公开(公告)号:US11833131B2
公开(公告)日:2023-12-05
申请号:US16491197
申请日:2018-03-05
Applicant: The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) , Mor Research Applications Ltd.
Inventor: Hinanit Koltai , Yoram Kapulnik , Moran Mazuz , Timna Naftali
IPC: A61K31/353 , A61K31/01 , A61K31/015 , A61K31/045 , A61K31/05 , A61K31/12 , A61K31/194 , A61P1/00 , A61P29/00 , A61K31/352 , A61K36/185 , A61K45/06
CPC classification number: A61K31/353 , A61K31/01 , A61K31/015 , A61K31/045 , A61K31/05 , A61K31/12 , A61K31/194 , A61K31/352 , A61K36/185 , A61P1/00 , A61P29/00 , A61K45/06
Abstract: A method of treating an inflammatory disease in a subject in need thereof is provided. The method comprising administering to the subject a therapeutically effective amount of a liquid chromatography fraction of a cannabis extract comprising at least 75% tetrahydrocannabinolic acid (THCA), wherein the fraction comprises cannabis derived active ingredients other than the THCA.
-
公开(公告)号:US20230076246A1
公开(公告)日:2023-03-09
申请号:US17800245
申请日:2020-02-17
Inventor: Eran SEGAL , Smadar SHILO , Yotam AMAR
Abstract: A method of predicting an analyte level comprises receiving a time-ordered series of levels of the analyte, monitored over a time-period; feeding a trained neural network procedure with the monitored levels; and displaying, based on an output received from the procedure, a predicted level of the analyte in a future time. The procedure can comprise a plurality of layers, wherein for at least one pair of layers, a number of inter-layer connections within the pair is higher for later monitored levels than for earlier monitored levels.
-
公开(公告)号:US11344225B2
公开(公告)日:2022-05-31
申请号:US14762819
申请日:2014-01-24
Inventor: Yaniv Zigel , Ariel Tarasiuk , Oren Elisha
Abstract: A method of determining a value for an apnea-hypopnea index (AHI) for a person, the method comprising: recording a voice track of a person; extracting features from the voice track that characterize the voice track; and processing the features to determine an AHI.
-
公开(公告)号:US20220082863A1
公开(公告)日:2022-03-17
申请号:US17536154
申请日:2021-11-29
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor: Gonen OMER , Ori MAHLER
Abstract: Embodiments concern an optical eye-contact device comprising a lens body having a symmetry axis and which further comprises a light-transmissive portion and an opaque portion, wherein the light-transmissive portion is decentered with respect to the symmetry axis.
-
公开(公告)号:US11217334B2
公开(公告)日:2022-01-04
申请号:US16073484
申请日:2017-02-27
Applicant: MOR RESEARCH APPLICATIONS LTD
Inventor: Doron Netzer , Dan Nabriski , Eytan Roitman
Abstract: Embodiments disclosed herein relate to a computerized method of selecting an optimal medication for a patient, comprising: providing a user with communication access to a central server having in memory a database of a rule set associated with a list of medications available, the rules set numerically ranking the suitability of a medication for a patient; allowing upload of at least a portion of an electronic medical record for an identified patient; allowing input of a patient diagnosis, and receiving a search request for a suitable treatment medication; comparing the rules set, with the uploaded electronic medical record; determining (e.g., scoring and calculating) the suitability of medications from the list of medications available; providing a displayable list of medications suited for the patient, wherein the list is ranked according to the preference of the medications for the patient.
-
公开(公告)号:US20210378538A1
公开(公告)日:2021-12-09
申请号:US17405424
申请日:2021-08-18
Applicant: MOR RESEARCH APPLICATIONS LTD
Inventor: Matan BEN DAVID , Amir KRAITZER
IPC: A61B5/053 , A61B5/0538 , A61B5/00 , A61B17/11
Abstract: Embodiments relate to an implantable device for detecting leakage of matter from a mammalian lumen, the device comprising a mesh structure that is attachable to a lumen of a mammalian. The mesh structure comprises a material or a material composition that is electrically conductive and which is measurably responsive in terms of its electrical conductivity when being subjected to leakage of matter from the lumen.
-
公开(公告)号:US11076856B2
公开(公告)日:2021-08-03
申请号:US16303188
申请日:2017-05-23
Applicant: Mor Research Applications Ltd.
Inventor: Doron Kopelman
IPC: A61B17/11 , A61B17/12 , A61B17/32 , A61B17/122 , A61B90/00 , A61B17/08 , A61B17/3205 , A61B17/115 , A61B17/00
Abstract: According to some embodiments there is provided an anastomosis device configured to reduce leakage, comprising: a first set of rings sized to be positioned at a first tissue wall; a second set of rings sized to be positioned at a second tissue wall adjacent the first tissue wall; and an element configured to draw the ring sets towards each other; wherein each set of rings comprises an inner ring, an outer ring, and a coupling for aligning the inner and outer rings with respect to each other; wherein the inner ring applies a first pressure onto the tissue wall which is sufficient to gradually form a passage between the first and second tissue walls; and the outer ring applies a second pressure onto the tissue wall, the second pressure applied radially outwardly relative to the first pressure, the second pressure sufficient to reduce leakage in a vicinity of the passage.
-
公开(公告)号:US10682328B2
公开(公告)日:2020-06-16
申请号:US15532116
申请日:2015-12-03
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor: Zeev Dvashi , Ayala Pollack
Abstract: This disclosure relates to compositions for use in treatment of Alzheimer's Disease, and/or a ocular and retinal degenerative disease, such as age related macular degeneration. The described compositions include effective amounts of LLMe, the hydrobromide form thereof, or functional derivatives thereof. Methods of treatment of a retinal degenerative disease of Alzheimer's Disease using the described compositions are also provided.
-
公开(公告)号:US20200009221A1
公开(公告)日:2020-01-09
申请号:US16287598
申请日:2019-02-27
Applicant: Ben Gurion University of the Negev Research and Development Authority , MOR - RESEARCH APPLICATIONS LTD.
Inventor: Abraham Parola , Ilana Nathan , Ron Kasher , Jenny Lerner Yardeni , Aviv Cohen
IPC: A61K38/17 , A61K31/4412 , A61K38/07 , A61K38/10
Abstract: A method of treating a patient suffering from a disease characterized by tissue necrosis by administering to the patient a necrosis inhibitor and/or a Humanin or a derivative of Humanin is provided. The invention further includes a method for prophylactically treating a patient at risk for a pathological condition that is precipitated at least in part by tissue necrosis by administering to the patient a necrosis inhibitor and/or a Humanin or a derivative of Humanin.
-
-
-
-
-
-
-
-
-